Andreessen Horowitz and Khosla Ventures led a $300m Series E round in Abridge.

Andreessen Horowitz, a venture capital firm focused on technology-driven companies, and Khosla Ventures, a venture capital firm, led a $300m Series E round in Abridge, a generative AI platform for clinical conversations. “Every medical conversation is rich with the signals our healthcare system depends on. Abridge activates those signals in the background, silently handling the complexity so clinicians can focus on the human moments that matter. We reduce the burden, restore time, and help make care about the people at the heart of it all,” Dr. Shiv Rao, Abridge CEO and Co-Founder.